GNH USA

Europe — EMA

Olmesartan+amlodipine Sandoz (Olmesartan Medoxomil, Amlodipine)

GNH USA supplies Olmesartan+amlodipine Sandoz (Olmesartan), a hypertension drug for combined ARB and calcium‑channel blocker therapy.

Olmesartan Medoxomil, Amlodipine

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Amlodipine?

Olmesartan medoxil, the active ingredient in Olmesartan+amlodipine Sandoz, is a angiotensin II receptor blocker presented as a fixed‑dose combination tablet for oral use. It treats hypertension, often in patients who require additional blood pressure control beyond monotherapy.

GNH USA supplies Olmesartan+amlodipine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Amlodipine used for?

Olmesartan+amlodipine Sandoz is used in cardiovascular therapy to manage high blood pressure through complementary mechanisms. - Hypertension: Provides additive blood pressure reduction when monotherapy is insufficient. - Isolated systolic hypertension in the elderly: Improves systolic control with a calcium‑channel blocker component. - Hypertensive patients with concomitant edema risk: Amlodipine’s vasodilatory effect mitigates fluid retention associated with some antihypertensives.

What are the side effects of Olmesartan Medoxomil, Amlodipine?

Adverse reactions reported with the fixed‑dose combination reflect the safety profiles of both components.

Common Side Effects: - Peripheral edema: mild swelling, often of the ankles. - Headache: transient, pressure‑type pain. - Dizziness or light‑headedness: especially after the first doses. - Flushing: warm sensation, usually short‑lived. - Fatigue: general tiredness without a clear cause.

Serious or Rare Side Effects: - Angio‑edema: rapid swelling of lips, tongue or airway. - Severe hypotension: symptomatic low blood pressure. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Cardiac arrhythmias: irregular heart rhythm. - Stevens‑Johnson syndrome: severe skin reaction.

What precautions apply to Olmesartan Medoxomil, Amlodipine?

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters. - Renal impairment: adjust dose and monitor creatinine clearance. - Hepatic disease: use with caution, observe liver function tests. - Electrolyte disturbances: check potassium and sodium levels. - Concomitant antihypertensives: avoid excessive blood‑pressure lowering. - Pregnancy: contraindicated in the second and third trimesters; discuss risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

What does Olmesartan Medoxomil, Amlodipine interact with?

Olmesartan+amlodipine Sandoz may alter the pharmacokinetics or pharmacodynamics of several co‑administered medicines.

Major Interactions (Avoid): - Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, other ARBs): risk of hyperkalaemia and renal failure. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): increase amlodipine exposure.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate hypotensive effect. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce antihypertensive efficacy and affect renal function. - Lithium: may increase serum lithium levels. - Simvastatin: higher risk of myopathy when combined with amlodipine. - Digoxin: monitor serum levels due to possible increased concentration.

Frequently asked questions

What is Olmesartan+amlodipine Sandoz used for?+
Olmesartan+amlodipine Sandoz is a fixed‑dose oral tablet that combines an angiotensin‑II receptor blocker with a calcium‑channel blocker. It is prescribed to lower high blood pressure in adults when a single‑agent regimen does not achieve target values, providing complementary mechanisms to improve cardiovascular risk management.
How does Olmesartan medoxil work in this combination?+
Olmesartan medoxil blocks AT1 receptors for angiotensin II, preventing vasoconstriction and aldosterone‑mediated fluid retention. Amlodipine, the second component, inhibits calcium entry into vascular smooth‑muscle cells, causing arterial dilation. Together they produce additive blood‑pressure reduction without competing for the same molecular target.
What is the usual dose of Olmesartan+amlodipine Sandoz?+
The prescribed dose of Olmesartan+amlodipine Sandoz is determined by the treating physician based on the patient’s blood‑pressure level, response to therapy, and any comorbid conditions. Dosage adjustments are made according to clinical guidelines and individual tolerance.
Is Olmesartan+amlodipine Sandoz safe during pregnancy or breastfeeding?+
Olmesartan+amlodipine Sandoz is contraindicated in the second and third trimesters of pregnancy because angiotensin‑II receptor blockers can harm the fetus. Safety during breastfeeding has not been established; therefore, it should be used only if the potential benefit justifies the possible risk to the infant.
How do I order Olmesartan+amlodipine Sandoz from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does this combination compare with other antihypertensive options?+
Compared with monotherapy using either an ARB or a calcium‑channel blocker, the Olmesartan+amlodipine fixed‑dose offers greater blood‑pressure reduction through two complementary pathways. It can replace the need for multiple separate pills, improving adherence, while maintaining a safety profile similar to the individual agents.
What are the storage and handling requirements for Olmesartan+amlodipine Sandoz?+
Store the tablets at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep them out of reach of children and do not use the product after the expiry date printed on the packaging.
How is Olmesartan+amlodipine Sandoz administered?+
The medication is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their healthcare professional.
What are the most serious risks associated with this medication?+
Serious adverse events include angio‑edema, severe hypotension, hepatic dysfunction, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience swelling of the face or throat, marked dizziness, or any signs of an allergic reaction.
Who should not use Olmesartan+amlodipine Sandoz?+
The combination should be avoided in patients with known hypersensitivity to olmesartan, amlodipine or any excipients, in those with severe hepatic impairment, and in pregnant women during the second and third trimesters. Caution is also advised for individuals with significant renal dysfunction.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Olmesartan Medoxomil, Amlodipine
Route
Oral Use
Manufacturer
Sandoz Gmbh
Origin
EU

Related products

Albis

Albis

Olmesartan Medoxomil, Amlodipine

Laboratorios Alter, S.A.
EU
Almacor Duo

Almacor Duo

Olmesartan Medoxomil, Amlodipine

Antibiotice Sa
EU
Alsamod

Alsamod

Olmesartan Medoxomil, Amlodipine

Krka, D.D., Novo Mesto
EU
Amelior

Amelior

Olmesartan Medoxomil, Amlodipine

Menarini International Operations Luxembourg S.A.
EU